Clinical Trials Directory

Trials / Suspended

SuspendedNCT04782336

Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test

Sample Collection to Facilitate the Performance Evaluation of the LumiraDx Point of Care Device for the Detection of Influenza A/B, Respiratory Syncytial Virus (RSV) & COVID-19 (SARS-COV-2 Virus)

Status
Suspended
Phase
N/A
Study type
Interventional
Enrollment
2,500 (estimated)
Sponsor
LumiraDx UK Limited · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Collection of Nasal Swabs, Throat Swabs and Saliva Samples from patients presenting at their designated care or testing facility displaying symptoms of either Influenza, Respiratory Syncytial Virus (RSV), SARS-CoV-2 or those who have been in recent contact with SARS-CoV-2 positive patients. Collected samples will aid the development, calibration and performance evaluation of the LumiraDx POC Test.

Detailed description

INFORM is a sample collection study targeting a population of patients attending their designated care or testing facility, suspected of having a respiratory illness typical of Influenza, RSV or COVID-19 and undergoing a Standard of Care (SOC) test on the day. Or those who have been in recent contact with SARS-CoV-2 positive patients. Participants may be of any age, there is no upper or lower age limit. Depending on the facility's viability and agreed contracting, the following study samples will be collected per patient: Adult Population: Two (2) Nasal, AND/OR Two (2) Throat Swabs AND/OR, One (1) Saliva Sample Paediatric Population: Two (2) Nasal, OR Two (2) Throat Swabs AND/OR, One (1) Saliva Sample Once required samples and data have been collected, participation is complete. No follow-up or subsequent patient involvement is required.

Conditions

Interventions

TypeNameDescription
OTHERSample CollectionSample Collection - Adult Population: * Two (2) Nasal AND/OR * Two (2) Throat Swabs AND/OR * One (1) Saliva Sample Sample Collection - Paediatric Population: * Two (2) Nasal OR * Two (2) Throat Swabs AND/OR * One (1) Saliva Sample

Timeline

Start date
2020-12-12
Primary completion
2024-06-30
Completion
2024-06-30
First posted
2021-03-04
Last updated
2024-01-26

Locations

6 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04782336. Inclusion in this directory is not an endorsement.